leadf
logo-loader
viewAccenture

Accenture tops earnings estimates

office350_5603e2b316a19.jpg
Earnings per share were three cents higher than expected at 115 cents.

Business consultancy Accenture (NYSE:ACN) marginally topped forecasts with its fiscal fourth quarter earnings.

Analysts had penciled in a figure of US$1.12 for earnings per share (EPS), but the firm reported EPS of US$1.15, up from US$1.08 in the same quarter of last year.

Net income in the three months to the end of August came in at US$778.6mln, versus US$744.7mln the year before.

Revenue rose to US$1.89bn from US$7.78bn.

Shares edged up 22 cents to US$97.89 in a falling market, and are up 9.6% year-to-date.


Quick facts: Accenture

Price: 252.27 USD

NYSE:ACN
Market: NYSE
Market Cap: $159.96 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Lexaria Bioscience proves technology works in enhancing oral delivery of...

Lexaria Bioscience (OTCQX:LXRP-CSE: LXX) CEO Chris Bunka joined Steve Darling from Proactive with news the company has announced that its DehydraTECH technology significantly improved delivery in study animals of representative drugs from two classes of antiviral therapies. Bunka telling...

1 hour, 17 minutes ago

2 min read